amrinone has been researched along with Aldosteronism in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Excerpt | Relevance | Reference |
---|---|---|
" Amrinone was administered to improve the features of congestive heart failure induced by retention of body fluid." | 3.70 | [General anesthesia for a patient with primary aldosteronism complicated with hypertrophic nonobstructive cardiomyopathy]. ( Kinoshita, T; Matsuda, T; Shigemi, K; Shimosato, G; Tanaka, Y, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shimosato, G | 1 |
Matsuda, T | 1 |
Shigemi, K | 1 |
Kinoshita, T | 1 |
Tanaka, Y | 1 |
1 other study available for amrinone and Aldosteronism
Article | Year |
---|---|
[General anesthesia for a patient with primary aldosteronism complicated with hypertrophic nonobstructive cardiomyopathy].
Topics: Adrenal Glands; Adult; Amrinone; Anesthesia, General; Cardiomyopathy, Hypertrophic; Heart Failure; H | 1999 |